CN106046089B - 一种治疗原发性或继发性白血病药物地西他滨的合成方法 - Google Patents
一种治疗原发性或继发性白血病药物地西他滨的合成方法 Download PDFInfo
- Publication number
- CN106046089B CN106046089B CN201610486864.8A CN201610486864A CN106046089B CN 106046089 B CN106046089 B CN 106046089B CN 201610486864 A CN201610486864 A CN 201610486864A CN 106046089 B CN106046089 B CN 106046089B
- Authority
- CN
- China
- Prior art keywords
- decitabine
- ribofuranoses
- synthetic method
- chloro
- deoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229960003603 decitabine Drugs 0.000 title claims abstract description 57
- XAUDJQYHKZQPEU-KVQBGUIXSA-N 5-aza-2'-deoxycytidine Chemical compound O=C1N=C(N)N=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 XAUDJQYHKZQPEU-KVQBGUIXSA-N 0.000 title claims abstract description 41
- 238000010189 synthetic method Methods 0.000 title claims abstract description 20
- 229940079593 drug Drugs 0.000 title claims abstract description 11
- 239000003814 drug Substances 0.000 title claims abstract description 11
- 208000032839 leukemia Diseases 0.000 title claims abstract description 10
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims abstract description 27
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 19
- UFMZWBIQTDUYBN-UHFFFAOYSA-N cobalt dinitrate Chemical compound [Co+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O UFMZWBIQTDUYBN-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229910001981 cobalt nitrate Inorganic materials 0.000 claims abstract description 16
- 238000005406 washing Methods 0.000 claims abstract description 16
- 239000000203 mixture Substances 0.000 claims abstract description 15
- 235000019441 ethanol Nutrition 0.000 claims abstract description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000000605 extraction Methods 0.000 claims abstract description 6
- 229950011260 betanaphthol Drugs 0.000 claims description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 14
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- 239000007789 gas Substances 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 4
- 230000001681 protective effect Effects 0.000 claims description 3
- 229910052786 argon Inorganic materials 0.000 claims description 2
- 239000001307 helium Substances 0.000 claims description 2
- 229910052734 helium Inorganic materials 0.000 claims description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 2
- 238000001953 recrystallisation Methods 0.000 abstract description 7
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 abstract description 2
- 238000013459 approach Methods 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 2
- 239000000460 chlorine Substances 0.000 abstract 2
- 229910052801 chlorine Inorganic materials 0.000 abstract 2
- 150000004786 2-naphthols Chemical class 0.000 abstract 1
- DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 abstract 1
- 150000000842 D-ribofuranoses Chemical class 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 150000003918 triazines Chemical class 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 description 8
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 0 *OC[C@@]1OCCC1O* Chemical compound *OC[C@@]1OCCC1O* 0.000 description 2
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- -1 dichloromethane Alkane Chemical class 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 230000000269 nucleophilic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 2
- SEICJBWXVKOVGZ-PYHARJCCSA-N (4S,5R)-2-chloro-5-(hydroxymethyl)oxolane-2,4-diol Chemical compound OC[C@H]1OC(O)(Cl)C[C@@H]1O SEICJBWXVKOVGZ-PYHARJCCSA-N 0.000 description 1
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical group C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 1
- PJKVFARRVXDXAD-UHFFFAOYSA-N 2-naphthaldehyde Chemical compound C1=CC=CC2=CC(C=O)=CC=C21 PJKVFARRVXDXAD-UHFFFAOYSA-N 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- BICHWYLZDOYTHS-PSGOWDBMSA-N C[C@H](CC([C@@H](CO)O)O)N(C=NCCC(N)=N1)C1=O Chemical compound C[C@H](CC([C@@H](CO)O)O)N(C=NCCC(N)=N1)C1=O BICHWYLZDOYTHS-PSGOWDBMSA-N 0.000 description 1
- 206010026851 Marrow hyperplasia Diseases 0.000 description 1
- ZGINPHARJIMXMG-VEGRVEBRSA-N O=C[C@H](O)[C@H](O)[C@H](O)CO.[O] Chemical compound O=C[C@H](O)[C@H](O)[C@H](O)CO.[O] ZGINPHARJIMXMG-VEGRVEBRSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229940123468 Transferase inhibitor Drugs 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- KTPIHRZQGZDLSN-UHFFFAOYSA-N cobalt;nitric acid Chemical compound [Co].O[N+]([O-])=O KTPIHRZQGZDLSN-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- XTVVROIMIGLXTD-UHFFFAOYSA-N copper(II) nitrate Chemical compound [Cu+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XTVVROIMIGLXTD-UHFFFAOYSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 239000003558 transferase inhibitor Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/12—Triazine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610486864.8A CN106046089B (zh) | 2016-06-27 | 2016-06-27 | 一种治疗原发性或继发性白血病药物地西他滨的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610486864.8A CN106046089B (zh) | 2016-06-27 | 2016-06-27 | 一种治疗原发性或继发性白血病药物地西他滨的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106046089A CN106046089A (zh) | 2016-10-26 |
CN106046089B true CN106046089B (zh) | 2018-09-11 |
Family
ID=57166002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610486864.8A Expired - Fee Related CN106046089B (zh) | 2016-06-27 | 2016-06-27 | 一种治疗原发性或继发性白血病药物地西他滨的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106046089B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1354046A (zh) * | 2001-11-16 | 2002-06-19 | 中国科学院上海有机化学研究所 | 催化不对称杂-Diels-Alder反应的催化剂、制备及其用途 |
CN101311184A (zh) * | 2007-05-25 | 2008-11-26 | 上海医药工业研究院 | 2-脱氧-d-核糖衍生物及其制备方法和用途 |
CN101883570A (zh) * | 2007-11-06 | 2010-11-10 | 药华医药股份有限公司 | β-核苷的新颖合成 |
CN101899079A (zh) * | 2009-05-30 | 2010-12-01 | 鲁南制药集团股份有限公司 | 一种地西他滨的制备和分离纯化方法 |
-
2016
- 2016-06-27 CN CN201610486864.8A patent/CN106046089B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1354046A (zh) * | 2001-11-16 | 2002-06-19 | 中国科学院上海有机化学研究所 | 催化不对称杂-Diels-Alder反应的催化剂、制备及其用途 |
CN101311184A (zh) * | 2007-05-25 | 2008-11-26 | 上海医药工业研究院 | 2-脱氧-d-核糖衍生物及其制备方法和用途 |
CN101883570A (zh) * | 2007-11-06 | 2010-11-10 | 药华医药股份有限公司 | β-核苷的新颖合成 |
CN101899079A (zh) * | 2009-05-30 | 2010-12-01 | 鲁南制药集团股份有限公司 | 一种地西他滨的制备和分离纯化方法 |
Non-Patent Citations (1)
Title |
---|
《Chiral catalysts for the asymmetric cycloaddition of carbon dioxide》;Jin, Lili; Huang, Yongzhong; Jing, Huanwang; 等;《TETRAHEDRON-ASYMMETRY》;20080822;第19卷(第16期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN106046089A (zh) | 2016-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111875517A (zh) | 用于合成喜树碱衍生物的中间体及其制备方法和用途 | |
EP4293026A1 (en) | High-purity thienopyrimidine compound and preparation method therefor | |
CA2577449C (en) | Method for the preparation of 2'-deoxy-2',2'-difluorocytidine | |
TW201103550A (en) | Process for producing fluorocytidine derivatives | |
EP2906530B1 (en) | Processes for the synthesis of 2-amino-4,6-dimethoxybenzamide and other benzamide compounds | |
CN106046089B (zh) | 一种治疗原发性或继发性白血病药物地西他滨的合成方法 | |
EP3527556B1 (en) | Method for preparing deuterated imidazole diketone compound | |
CN104926900B (zh) | 一种制备式i所示的卡培他滨中间体的方法 | |
CN109438374B (zh) | 卢非酰胺的连续化合成方法 | |
CN112939814A (zh) | 一种氘代达卡他韦中间体的制备方法 | |
JP2000502102A (ja) | 9,11β―エポキシドステロイドの調製方法 | |
CN113754632A (zh) | 一种癌症治疗药物的制备方法 | |
CN112552283A (zh) | 一种新型替尼类药物的制备方法 | |
CN112079894B (zh) | 一种左炔诺孕酮药典杂质v的制备方法 | |
CN110698529A (zh) | 一种依普利酮中间体△9,11烯酯的制备方法 | |
CN106317064B (zh) | 溴甲纳曲酮的制备方法 | |
CN115850237A (zh) | 一种吲哚衍生物的合成方法 | |
EP3026047A1 (en) | Method for producing heterocyclic compound | |
CN114940695B (zh) | 一种具有抗肿瘤活性的雄诺龙衍生物及其制备方法与应用 | |
CN106117290A (zh) | 一种抗癌药物地西他滨的制备方法 | |
JP6275596B2 (ja) | テルミサルタンのアンモニウム塩の製造方法 | |
CN109020915A (zh) | 一种提高1,2-重氮氧基萘-4-磺酸的硝化选择性的方法 | |
EP3719002B1 (en) | Method for preparing salicylamide acetate | |
CN109796513A (zh) | 一种化合物及其制备方法和用途 | |
CN117603158A (zh) | 一种d-荧光素以及d-荧光素钾盐的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Ying Inventor after: Zhang Xiyuan Inventor after: Wang Peijun Inventor after: Wang Chuanxiu Inventor before: Wang Chuanxiu |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20180802 Address after: 266011 Qingdao City Central Hospital, 127 South four road, Qingdao, Shandong Applicant after: Li Ying Address before: 266109 office 825, building 1, 205 Zhengyang Road, Chengyang District, Qingdao, Shandong. Applicant before: The skies, Qingdao Bioisystech Co., Ltd |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200114 Address after: 266011 Qingdao City Central Hospital, 127 South four road, Qingdao, Shandong Patentee after: Zhongxin Hospital, Qingdao Address before: 266011 Qingdao City Central Hospital, 127 South four road, Qingdao, Shandong Patentee before: Li Ying |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180911 Termination date: 20190627 |